Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
20.74
-0.75 (-3.49%)
At close: Apr 29, 2026, 4:00 PM EDT
20.60
-0.14 (-0.68%)
After-hours: Apr 29, 2026, 4:10 PM EDT
Lyell Immunopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -274.45 | -342.99 | -234.63 | -183.12 | -250.22 | |
| Depreciation & Amortization | 11.54 | 19.63 | 20.25 | 18.02 | 13.62 | |
| Loss (Gain) From Sale of Assets | 3.34 | 1.34 | 1.51 | 0.1 | 1.21 | |
| Asset Writedown & Restructuring Costs | 67.78 | 138.48 | - | - | - | |
| Loss (Gain) From Sale of Investments | 14.26 | -1.71 | 3.33 | 1.15 | 38.35 | |
| Stock-Based Compensation | 41.83 | 33.14 | 47.08 | 81.92 | 62.2 | |
| Other Operating Activities | -4.43 | -7.17 | -4.65 | -5.62 | 4.57 | |
| Change in Accounts Payable | -2.34 | -3.23 | 1.46 | 0.67 | 0.09 | |
| Change in Unearned Revenue | - | - | - | -84.65 | -10.51 | |
| Change in Other Net Operating Assets | -7.56 | 0.11 | 1.96 | 1.97 | 14.43 | |
| Operating Cash Flow | -150.02 | -162.39 | -163.69 | -169.56 | -126.25 | |
| Capital Expenditures | -0.78 | -0.46 | -2.69 | -24.28 | -65.5 | |
| Sale of Property, Plant & Equipment | 0.29 | - | - | - | - | |
| Cash Acquisitions | -41.2 | -31.35 | - | - | - | |
| Investment in Securities | 95.79 | 154.23 | 186.73 | 12.74 | -56.07 | |
| Investing Cash Flow | 54.1 | 122.42 | 184.05 | -11.54 | -121.57 | |
| Issuance of Common Stock | 50.41 | 1.4 | 2.2 | 11.1 | 401.24 | |
| Repurchase of Common Stock | -0 | -0.08 | -0.46 | -0.46 | - | |
| Financing Cash Flow | 50.41 | 1.33 | 1.74 | 10.64 | 401.24 | |
| Net Cash Flow | -45.52 | -38.64 | 22.1 | -170.46 | 153.42 | |
| Free Cash Flow | -150.8 | -162.86 | -166.38 | -193.83 | -191.75 | |
| Free Cash Flow Margin | -418900.00% | -266980.33% | -127984.62% | -228.89% | -1800.50% | |
| Free Cash Flow Per Share | -8.82 | -12.46 | -13.26 | -15.69 | -28.22 | |
| Levered Free Cash Flow | -81.47 | -67.56 | -90.36 | -53.9 | -129.82 | |
| Unlevered Free Cash Flow | -81.47 | -67.56 | -90.36 | -53.9 | -129.82 | |
| Change in Working Capital | -9.89 | -3.12 | 3.42 | -82.02 | 4.01 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.